Diesinger, T., Lautwein, A., Bergler, S., Buckert, D., Renz, C., Dvorsky, R., Buko, V., Kirko, S., Schneider, E., Kuchenbauer, F., Kumar, M., Günes, C., Genze, F., Büchele, B., Simmet, T., Haslbeck, M., Masur, K., Barth, T., Müller-Enoch, D., Wirth, T., & Haehner, T. (2021). a New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma. Canadian journal of gastroenterology & hepatology, 2021, . http://access.bl.uk/ark:/81055/vdc_100120461650.0x00000c